- Home
- BTAI vs TELA Comparison
BTAI vs TELA Comparison
Compare BTAI & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTAI | TELA |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 51.2M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BTAI | TELA |
|---|---|---|
| Price | $1.87 | $1.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $32.80 | $3.31 |
| AVG Volume (30 Days) | ★ 540.0K | 176.6K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $752,000.00 | ★ $77,055,000.00 |
| Revenue This Year | N/A | $18.39 |
| Revenue Next Year | $416.40 | $15.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.24 |
| 52 Week Low | $1.17 | $0.86 |
| 52 Week High | $9.26 | $3.10 |
Technical Indicators
Market Signals| Indicator | BTAI | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | 45.62 |
| Support Level | $1.82 | $1.09 |
| Resistance Level | $2.30 | $1.18 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 5.83 | 41.67 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.